Identification of a novel phosphorylation site of acyl-CoA binding protein (ACBP) in nodularin-induced apoptotic hepatocytes.

[1]  B. Kragelund,et al.  Acyl-CoA-binding protein (ACBP) localizes to the endoplasmic reticulum and Golgi in a ligand-dependent manner in mammalian cells. , 2008, The Biochemical journal.

[2]  C. Gieger,et al.  Association of acyl-CoA-binding protein (ACBP) single nucleotide polymorphisms and type 2 diabetes in two German study populations. , 2007, Molecular nutrition & food research.

[3]  J. G. Pastorino,et al.  Acyl Coenzyme A-binding Protein Augments Bid-induced Mitochondrial Damage and Cell Death by Activating μ-Calpain* , 2006, Journal of Biological Chemistry.

[4]  R. Gross,et al.  Highly Selective Hydrolysis of Fatty Acyl-CoAs by Calcium-independent Phospholipase A2β , 2006, Journal of Biological Chemistry.

[5]  T. Solstad,et al.  Algal toxins as guidance to identify phosphoproteins with key roles in apoptotic cell death. , 2006, Current pharmaceutical biotechnology.

[6]  F. Schroeder,et al.  Acyl-CoA binding proteins: Multiplicity and function , 1996, Lipids.

[7]  B. Atshaves,et al.  Acyl-coenzyme A binding protein expression alters liver fatty acyl-coenzyme A metabolism. , 2005, Biochemistry.

[8]  P. Roepstorff,et al.  Highly Selective Enrichment of Phosphorylated Peptides from Peptide Mixtures Using Titanium Dioxide Microcolumns* , 2005, Molecular & Cellular Proteomics.

[9]  G. Kroemer,et al.  Palmitate induces apoptosis via a direct effect on mitochondria , 1999, Apoptosis.

[10]  M. Jensen,et al.  Role of acylCoA binding protein in acylCoA transport, metabolism and cell signaling , 1999, Molecular and Cellular Biochemistry.

[11]  J. Knudsen.  Acyl-CoA-binding protein (ACBP) and its relation to fatty acid-binding protein (FABP): an overview , 2004, Molecular and Cellular Biochemistry.

[12]  J. Knudsen,et al.  Acyl-CoA binding protein is an essential protein in mammalian cell lines. , 2002, The Biochemical journal.

[13]  F. Schroeder,et al.  Membrane charge and curvature determine interaction with acyl-CoA binding protein (ACBP) and fatty acyl-CoA targeting. , 2002, Biochemistry.

[14]  P. Vandenabeele,et al.  A matrix-assisted laser desorption ionization post-source decay (MALDI-PSD) analysis of proteins released from isolated liver mitochondria treated with recombinant truncated Bid , 2002, Cell Death and Differentiation.

[15]  C. Ong,et al.  Calpain activation after mitochondrial permeability transition in microcystin-induced cell death in rat hepatocytes. , 2002, Biochemical and biophysical research communications.

[16]  T. Utsumi,et al.  Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition. , 2001, Biochemical pharmacology.

[17]  M. Wieckowski,et al.  Long‐chain fatty acids promote opening of the reconstituted mitochondrial permeability transition pore , 2000, FEBS letters.

[18]  K. Kristiansen,et al.  Long-chain acyl-CoA esters and acyl-CoA binding protein are present in the nucleus of rat liver cells. , 2000, Journal of lipid research.

[19]  B. Zhivotovsky,et al.  Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors , 1999, Cell Death and Differentiation.

[20]  J. DeGnore,et al.  Fragmentation of phosphopeptides in an ion trap mass spectrometer , 1998, Journal of the American Society for Mass Spectrometry.

[21]  N. Færgeman,et al.  Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. , 1997, The Biochemical journal.

[22]  T. Honjo,et al.  Inhibition of Carnitine Palmitoyltransferase I Augments Sphingolipid Synthesis and Palmitate-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[23]  S. Døskeland,et al.  Okadaic acid, cAMP, and selected nutrients inhibit hepatocyte proliferation at different stages in G1: Modulation of the cAMP effect by phosphatase inhibitors and nutrients , 1995, Journal of cellular physiology.

[24]  A. Khar,et al.  Apoptosis: Programmed cell death in health and disease , 1994, Bioscience reports.

[25]  J. Knudsen,et al.  Interaction of acyl-CoA binding protein (ACBP) on processes for which acyl-CoA is a substrate, product or inhibitor. , 1993, The Biochemical journal.

[26]  J. Knudsen,et al.  Characterization of ligand binding to acyl-CoA-binding protein. , 1993, The Biochemical journal.

[27]  P. D. Stefanis,et al.  Modulation of insulin secretion by diazepam binding inhibitor and its processing products , 1991, Neuropharmacology.

[28]  J. Zwiller,et al.  Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases. , 1991, Molecular pharmacology.

[29]  A. Guidotti,et al.  Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. , 1991, Endocrinology.

[30]  Å. Sjöholm,et al.  Long term inhibitory effects of pancreastatin and diazepam binding inhibitor on pancreatic beta-cell deoxyribonucleic acid replication, polyamine content, and insulin secretion. , 1991, Endocrinology.

[31]  I. Falconer,et al.  The uptake of the cyanobacterial hepatotoxin microcystin by isolated rat hepatocytes. , 1991, Toxicon : official journal of the International Society on Toxinology.

[32]  J. Knudsen,et al.  Comparison of the binding affinities of acyl-CoA-binding protein and fatty-acid-binding protein for long-chain acyl-CoA esters. , 1990, The Biochemical journal.

[33]  P. Højrup,et al.  Acyl-CoA-binding protein in the rat. Purification, binding characteristics, tissue concentrations and amino acid sequence. , 1989, The Biochemical journal.

[34]  B. Horecker,et al.  An endogenous activator of the Ca2+-dependent proteinase of human neutrophils that increases its affinity for Ca2+. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  I. Falconer,et al.  Toxicity of the cyanobacterium Nodularia spumigena Mertens. , 1988, Toxicon : official journal of the International Society on Toxinology.

[36]  J. Mikkelsen,et al.  Acyl-CoA-binding protein from cow. Binding characteristics and cellular and tissue distribution. , 1987, The Biochemical journal.

[37]  A. Guidotti,et al.  Cloning and expression of cDNA for human diazepam binding inhibitor, a natural ligand of an allosteric regulatory site of the gamma-aminobutyric acid type A receptor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Guidotti,et al.  Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Feuvray,et al.  Metabolic products and myocardial ischemia. , 1981, The American journal of pathology.

[40]  P. Seglen.  Preparation of isolated rat liver cells. , 1976, Methods in cell biology.